Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | Director | April 01, 2024 | April 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date April 01, 2024 · Filed April 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,900 |
Ending reported balance
After 2024-04-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-04-01 · Exercise / conversion · Acquired 296 · Balance 10,932 Row 2 · 2024-04-01 · Sale · Disposed 32 · Balance 10,900 F1: Reflects shares sold to cover taxes upon the option exercise pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.00 · Expires 2028-05-02 | Direct | 0 |
Reported balance
After 2024-04-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-04-01 · Exercise / conversion · Disposed 296 · Balance 0 F2: The option is fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares sold to cover taxes upon the option exercise pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: The option is fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 12, 2023 Filed Jun 14, 2023 21:56 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-23-071297 · tm2318710-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 21:57 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-23-068991 · tm2318172-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 21:57 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $305.69 | $152,845.00 |
DisclosureSEC source: 0001104659-23-068991 · tm2318172-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,084 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 21:57 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 29 | $305.69 | $8,865.01 |
DisclosureSEC source: 0001104659-23-068991 · tm2318172-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,584 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 21:57 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-23-068991 · tm2318172-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 21:59 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-23-067154 · tm2317615-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 21:59 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $294.90 | $147,450.00 |
DisclosureSEC source: 0001104659-23-067154 · tm2317615-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,613 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 21:59 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 29 | $294.90 | $8,552.10 |
DisclosureSEC source: 0001104659-23-067154 · tm2317615-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,113 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 21:59 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-23-067154 · tm2317615-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,142 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:04 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064115 · tm2316906-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:04 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $307.52 | $153,760.00 |
DisclosureSEC source: 0001104659-23-064115 · tm2316906-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,142 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:04 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 29 | $307.52 | $8,918.08 |
DisclosureSEC source: 0001104659-23-064115 · tm2316906-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,642 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:04 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-23-064115 · tm2316906-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2023 Filed May 18, 2023 00:23 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-23-062003 · tm2316151-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| May 15, 2023 Filed May 18, 2023 00:23 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $293.91 | $146,955.00 |
DisclosureSEC source: 0001104659-23-062003 · tm2316151-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,671 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 15, 2023 Filed May 18, 2023 00:23 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 29 | $293.91 | $8,523.39 |
DisclosureSEC source: 0001104659-23-062003 · tm2316151-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,171 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 15, 2023 Filed May 18, 2023 00:23 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-23-062003 · tm2316151-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-23-058640 · tm2315326-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $280.00 | $140,000.00 |
DisclosureSEC source: 0001104659-23-058640 · tm2315326-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,200 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 29 | $280.00 | $8,120.00 |
DisclosureSEC source: 0001104659-23-058640 · tm2315326-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,700 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-23-058640 · tm2315326-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2023 Filed May 1, 2023 23:45 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-054641 · tm2314266-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,729 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 02:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,759 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-22-118865 · tm2230411-1_4seq1.xml · derivative · entry 6 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,759 shares Expires 2027-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 02:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,518 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-22-118865 · tm2230411-1_4seq1.xml · derivative · entry 5 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,518 shares Expires 2027-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 02:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,266 | $222.12 | $725,443.92 |
DisclosureSEC source: 0001104659-22-118865 · tm2230411-1_4seq1.xml · nonDerivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,060 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.05 to $222.38. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 02:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 5,951 | $221.04 | $1,315,409.04 |
DisclosureSEC source: 0001104659-22-118865 · tm2230411-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,326 Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 02:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 3,759 | $0.94 | $3,533.46 |
DisclosureSEC source: 0001104659-22-118865 · tm2230411-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 02:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 7,518 | $0.94 | $7,066.92 |
DisclosureSEC source: 0001104659-22-118865 · tm2230411-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2022 Filed May 11, 2022 00:50 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantStock Option (right to buy) · Derivative | 1,243 | $0.00 Strike: $211.29 | $0.00 |
DisclosureSEC source: 0001104659-22-058420 · tm2215111-6_4seq1.xml · derivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,243 Underlying: Common Stock · 1,243 shares Expires 2032-04-28 F1 · derivative.exercise_date: The option vests and becomes exercisable on April 28, 2023, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantStock Option (right to buy) · Derivative | 1,175 | $0.00 Strike: $240.68 | $0.00 |
DisclosureSEC source: 0001104659-21-060317 · tm2114992-5_4seq1.xml · derivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,175 Underlying: Common Stock · 1,175 shares Expires 2031-04-29 F1 · derivative.exercise_date: The option vests and becomes exercisable on April 29, 2022, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 20:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,002 | $116.28 | $232,792.56 |
DisclosureSEC source: 0001104659-20-100186 · a4.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.20 to $116.38. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 20:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 15,546 | $115.70 | $1,798,672.20 |
DisclosureSEC source: 0001104659-20-100186 · a4.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,002 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.19 to $116.16. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 20:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 11,252 | $114.67 | $1,290,266.84 |
DisclosureSEC source: 0001104659-20-100186 · a4.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,548 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.18 to $115.16. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 30, 2020 Filed May 5, 2020 00:38 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantStock Option (right to buy) · Derivative | 3,501 | $0.00 Strike: $71.66 | $0.00 |
DisclosureSEC source: 0001104659-20-056417 · a4.xml · derivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,501 Underlying: Common Stock · 3,501 shares Expires 2030-04-30 F1 · derivative.exercise_date: The option vests and becomes exercisable on April 30, 2021, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| January 22, 2020 Filed Jan 23, 2020 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,312 | $80.93 | $106,180.16 |
DisclosureSEC source: 0001104659-20-006316 · a4.xml · nonDerivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,800 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.55 to $81.23. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 100 | $83.23 | $8,323.00 |
DisclosureSEC source: 0001104659-20-006316 · a4.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,112 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,600 | $82.49 | $131,984.00 |
DisclosureSEC source: 0001104659-20-006316 · a4.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,212 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.14 to $83.11. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,300 | $81.60 | $269,280.00 |
DisclosureSEC source: 0001104659-20-006316 · a4.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,812 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.09 to $82.03. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 21:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,400 | $75.89 | $106,246.00 |
DisclosureSEC source: 0001104659-20-002288 · a4.xml · nonDerivative · entry 7 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,112 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.41 to $76.33. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 21:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,600 | $74.90 | $269,640.00 |
DisclosureSEC source: 0001104659-20-002288 · a4.xml · nonDerivative · entry 6 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,512 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.38 to $75.27. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,500 | $75.70 | $113,550.00 |
DisclosureSEC source: 0001104659-20-002288 · a4.xml · nonDerivative · entry 5 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,112 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.29 to $76.07. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,060 | $74.54 | $79,012.40 |
DisclosureSEC source: 0001104659-20-002288 · a4.xml · nonDerivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,612 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.22 to $75.20. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,140 | $73.57 | $83,869.80 |
DisclosureSEC source: 0001104659-20-002288 · a4.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,672 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.18 to $74.12. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,194 | $72.58 | $86,660.52 |
DisclosureSEC source: 0001104659-20-002288 · a4.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,812 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.15 to $73.015. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 106 | $71.21 | $7,548.26 |
DisclosureSEC source: 0001104659-20-002288 · a4.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,006 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.11 to $72.06. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $71.49 | $35,745.00 |
DisclosureSEC source: 0001104659-19-075005 · a4.xml · nonDerivative · entry 5 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,112 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.24 to $72.13. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 4,500 | $70.61 | $317,745.00 |
DisclosureSEC source: 0001104659-19-075005 · a4.xml · nonDerivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,612 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.20 to $71.15. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 200 | $72.39 | $14,478.00 |
DisclosureSEC source: 0001104659-19-075005 · a4.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,112 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.38 to $72.39. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,100 | $72.03 | $223,293.00 |
DisclosureSEC source: 0001104659-19-075005 · a4.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,312 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.35 to $72.32. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,700 | $71.07 | $120,819.00 |
DisclosureSEC source: 0001104659-19-075005 · a4.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,412 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.35 to $71.34. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.